Both in Biotechnology
Sutro Biopharma vs Coherus Oncology
Over the past year STRO returned −17.3% and CHRS returned −48.1%; their daily moves had a correlation of 0.22.
STRO −17.3% CHRS −48.1%Growth of $1, one year, split-adjusted
| Metric | STRO | CHRS |
|---|---|---|
| Price | $9.10 | $0.8301 |
| Market cap | $150.9M | $128.3M |
| Today | −0.44% | −7.60% |
| 1 month | −43.0% | −28.4% |
| 6 months | −74.4% | −53.9% |
| Year to date | −21.3% | −41.5% |
| 1 year | −13.3% | −52.0% |
| Revenue growth (YoY) | −84.6% | +39.5% |
| Gross margin | 100.0% | 70.4% |
| Net margin | −391.6% | −144.2% |
| P/E (TTM) | — | — |
| Price / sales | 3.3× | 2.5× |
| Net cash | $164.3M | $68.1M |
| Dividend yield | — | — |
| Volatility (60d) | 74.6% | 91.2% |
| Short % of float | 13.1% | 9.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).